Retatrutide vs Tirzepatide
Retatrutide and Tirzepatide are multi-receptor compounds studied in the recomposition category. This page sets their published specifications side by side and links to the full research overview for each. It makes no efficacy claims.
| Spec | Retatrutide | Tirzepatide |
|---|---|---|
| Category | Recomp | Recomp |
| CAS | 2381089-83-2 | 2023788-19-2 |
| Formula | C₂₂₁H₃₄₃N₅₁O₆₇ | C₂₂₅H₃₄₈N₄₈O₆₈ |
| MW | 4731.6 g/mol | 4813.45 g/mol |
| Price | from $149 | Sold out |
| Research overview | Read → | Read → |
| Certificate of analysis | View → | View → |
| Product | View Retatrutide → | View Tirzepatide → |
Frequently asked
What is the difference between Retatrutide and Tirzepatide?
They are different research compounds with different peptide sequences, molecular weights, and CAS numbers, compared side by side in the table above. The mechanism and the published research for each is covered in its individual research overview, linked below.
Are Retatrutide and Tirzepatide both third-party tested?
Check the Certificate of analysis row above. A linked entry has a certificate in the public COA ledger. An entry marked No published COA is not presented as certified.
Are Retatrutide and Tirzepatide for human use?
No. Both are research compounds intended for laboratory and in-vitro research use only. Not for human consumption.
Which one should I research?
That depends on your research focus. Read each compound's research overview for what the literature reports, and if you are unsure, ask the research team on chat. We do not make the choice for you or provide dosing guidance.
For educational purposes only. Not medical advice. Research-use only. This comparison lists published specifications and does not rank the compounds or make efficacy claims. See our research disclaimer.